COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI was delisted on the 3rd of September, 2025.
31 hedge funds and large institutions have $2.29M invested in COSCIENS Biopharma Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.
427% more capital invested
Capital invested by funds: $434K → $2.29M (+$1.86M)
220% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 5
199% more call options, than puts
Call options by funds: $2.17M | Put options by funds: $725K
55% more funds holding
Funds holding: 20 → 31 (+11)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$663K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$378K |
| 3 |
Millennium Management
New York
|
+$238K |
| 4 |
VF
Virtu Financial
New York
|
+$177K |
| 5 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
+$111K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$540K |
| 2 |
Two Sigma Advisers
New York
|
-$79K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$53.7K |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$17.4K |
| 5 |
SFP
Sandbox Financial Partners
Bethesda,
Maryland
|
-$8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TC
26
Truvestments Capital
Sarasota,
Florida
| $3K | +$776 | +7 | +32% |
|
|
FWM
27
Focused Wealth Management
Newburgh,
New York
| $1K | -$1.11K | -10 | -50% |
|
28
Citigroup
New York
| $1K | – | – | – |
|
|
RIM
29
Rockbridge Investment Management
Syracuse,
New York
| $1K | – | – | – |
|
|
SPIA
30
Steward Partners Investment Advisory
New York
| $8 | – | – | – |
|
|
31
Two Sigma Advisers
New York
| – | -$79K | -1,855 | Closed |
|
|
SFP
32
Sandbox Financial Partners
Bethesda,
Maryland
| – | -$8K | -195 | Closed |
|
|
RFA
33
Reilly Financial Advisors
La Mesa,
California
| – | -$6K | -130 | Closed |
|
|
DWM
34
Dorchester Wealth Management
Montreal,
Quebec, Canada
| – | -$4K | -100 | Closed |
|
|
IF
35
Ironwood Financial
Tucson,
Arizona
| – | +$111 | +1 | New |
|
CSCI Hedge Fund Activity: Q1 2021 in Review
31 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q1 2021, worth a combined $2.29M — up 427% from $434K a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new CSCI positions and 5 closed out — a net gain of 11 holders — while 6 added to existing stakes and 5 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $663K. The largest seller was Morgan Stanley, cutting an estimated $540K.
- 31 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q1 2021, up from 20 in Q4 2020.
- Funds reported $2.29M of COSCIENS Biopharma Inc. Common Stock stock for Q1 2021, up 427% quarter-over-quarter.
- 16 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q1 2021 and 5 closed out, a net change of +11 holders.
- The largest COSCIENS Biopharma Inc. Common Stock buyer in Q1 2021 was Sabby Management, an estimated $663K added.
- The largest COSCIENS Biopharma Inc. Common Stock seller in Q1 2021 was Morgan Stanley, an estimated $540K sold.
Based on aggregated 13F filings for Q1 2021.